7:34 PM
 | 
Feb 19, 2009
 |  BC Extra  |  Financial News

BioMarin off after earnings, guidance

BioMarin (NASDAQ:BMRN) fell $5.65 (32%) to $12.04 on Thursday after reporting 4Q08 and FY08 earnings that missed the Street's estimates and 2009 revenue guidance that also came in below...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >